Grant: New Frontiers in Research Fund - Exploration
Dalhousie University
$125,000.00
Genetic engineering of T cells to target pathogenic antigen-presenting cells in Primary Biliary Cholangitis treatment
FY 2022-23
Program
New Frontiers in Research Fund - Exploration
Recipient
Location
Nova Scotia, Canada
Recipient Type
Academia
Type
Grant
Source
SSHRC's Expenditures File
As published
Cle
102741
File number
NFRFE-2022-00882
Name nom
Sokke Umeshappa, Channakeshava
Role rôle
Applicant
Amount montant
125000.0
Fiscal year exercice financier
2022
Institution
Dalhousie University
Établissement
Dalhousie University
Province id
NS
Province en
Nova Scotia
Province fr
Nouvelle-Écosse
Competition year année du concours
2022
Title titre
Genetic engineering of T cells to target pathogenic antigen-presenting cells in Primary Biliary Cholangitis treatment
Keywords mots clés
Primary Biliary Cholangitis Disease-specific treatment Synthetic biology Chimeric antigen receptor T cells peptide-presenting MHC II molecules Antigen-presenting cells Chronic diseases E2 component of the pyruvate dehydrogenase complex (PDC-E2)
Program
New Frontiers in Research Fund - Exploration
Programme
Fonds Nouvelles frontières en recherche - Exploration
Sshrc discipline en
Immunology
Crsh discipline fr
Immunologie
Sshrc main discipline
Basic medicine and life sciences
Crsh discipline principale
Médecine fondamentale et sciences de la vie
Sshrc area of research
Not Subject to Research Classification
Crsh domaine de recherche
Sans objet
Crdc field of research
Autoimmunity
Ccrd domaine de recherche
Auto-immunité
